You might be given blood-thinning medications after you've had a stroke, to help you avoid another one. Or you might need blood-thinning medication if you have a health condition such as a heart problem or blood-clotting disorder which could lead to a stroke.
This research project aims to better understand how particular features of the CT scan can be used to make better treatment decisions for patients with ischaemic stroke, and whether we can accurately estimate the time since the stroke began.
The International Stroke Conference (ISC) 2018 took place in Los Angeles (24-26 January).
The ISC is the world's largest meeting dedicated to the science and treatment of stroke and its effects. Check out some of the highlights from 2018.
Find out about the different treatments available to combat a stroke, including thrombolysis and thrombectomy.
The first day of the European Stroke Organisation Conference (ESOC) 2017 in Prague included some truly inspiring scientific sessions. These included reporting from the DAWN study which suggests that more patients could be able to receive mechanical thrombectomy after stroke.
UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway.
Published in the journal, Lancet Neurology, a new study suggests that understanding stroke severity, as well as time to treatment, is key to delivering effective and safe thrombolysis treatment.
Video interview highlights from ten key trials that presented at ESOC 2016.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.
Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016) today in Barcelona. Today’s program included teaching courses, scientific presentations, an official welcome from the ESOC President Professor Kennedy Lees and from Professor Angel Chamorro, and presentations from major clinical trials.